{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:51:20Z","timestamp":1790661080077,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":2794,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Charles Wolfson Charitable Trust"},{"DOI":"10.13039\/501100000265","name":"The Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norwegian Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012619","name":"Norman Collisson Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000852","name":"Henry Smith Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000852","id-type":"DOI","asserted-by":"publisher"}]},{"name":"John Coates Charitable Trust"},{"name":"Thames Valley Dementias and Neurodegenerative Diseases Research Network of the National Institute for Health Research"},{"name":"Sidney and Elizabeth Corob Charitable Trust"},{"name":"Meda AB\/Recip AB"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.3945\/ajcn.114.103283","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T00:44:05Z","timestamp":1429145045000},"page":"215-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"title":["Brain atrophy in cognitively impaired elderly: the importance of long-chain \u03c9-3 fatty acids and B vitamin status in a randomized controlled trial"],"prefix":"10.1016","volume":"102","author":[{"given":"Fredrik","family":"Jerner\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany K","family":"Elshorbagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderrahim","family":"Oulhaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Refsum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A David","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/ajcn.114.103283_bib1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","article-title":"Mild cognitive impairment","volume":"367","author":"Gauthier","year":"2006","journal-title":"Lancet"},{"key":"10.3945\/ajcn.114.103283_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.3945\/ajcn.114.103283_bib3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.52.8.1687","article-title":"Correlation between rates of brain atrophy and cognitive decline in AD","volume":"52","author":"Fox","year":"1999","journal-title":"Neurology"},{"key":"10.3945\/ajcn.114.103283_bib4","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1073\/pnas.082107399","article-title":"Imaging the progression of Alzheimer pathology through the brain","volume":"99","author":"Smith","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3945\/ajcn.114.103283_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","article-title":"Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD","volume":"62","author":"Jack","year":"2004","journal-title":"Neurology"},{"key":"10.3945\/ajcn.114.103283_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156720509788929273","article-title":"Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort","volume":"6","author":"Risacher","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"10.3945\/ajcn.114.103283_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1259\/bjr.75.894.750506","article-title":"Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer\u2019s disease","volume":"75","author":"Bradley","year":"2002","journal-title":"Br J Radiol"},{"key":"10.3945\/ajcn.114.103283_bib8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/01.wnl.0000180958.22678.91","article-title":"Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI","volume":"65","author":"Jack","year":"2005","journal-title":"Neurology"},{"key":"10.3945\/ajcn.114.103283_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3233\/JAD-2010-090934","article-title":"Omega-3 fatty acids, cognitive decline, and Alzheimer\u2019s disease: a critical review and evaluation of the literature","volume":"21","author":"Huang","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3945\/ajcn.114.103283_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/1471-2458-14-643","article-title":"Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis","volume":"14","author":"Beydoun","year":"2014","journal-title":"BMC Public Health"},{"key":"10.3945\/ajcn.114.103283_bib11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.0b013e318249f6a9","article-title":"Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging","volume":"78","author":"Tan","year":"2012","journal-title":"Neurology"},{"key":"10.3945\/ajcn.114.103283_bib12","doi-asserted-by":"crossref","first-page":"e000305","DOI":"10.1161\/JAHA.113.000305","article-title":"Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: the cardiovascular health study","volume":"2","author":"Virtanen","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.3945\/ajcn.114.103283_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.0000000000000080","article-title":"Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study","volume":"82","author":"Pottala","year":"2014","journal-title":"Neurology"},{"key":"10.3945\/ajcn.114.103283_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0b013e318264e394","article-title":"Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe","volume":"79","author":"Samieri","year":"2012","journal-title":"Neurology"},{"key":"10.3945\/ajcn.114.103283_bib15","first-page":"CD005379","article-title":"Omega 3 fatty acid for the prevention of cognitive decline and dementia","volume":"6","author":"Sydenham","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3945\/ajcn.114.103283_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/alzrt61","article-title":"What was lost in translation in the DHA trial is whom you should intend to treat","volume":"3","author":"Frautschy","year":"2011","journal-title":"Alzheimers Res Ther"},{"key":"10.3945\/ajcn.114.103283_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jalz.2010.08.234","article-title":"Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants","volume":"7","author":"Wald","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.3945\/ajcn.114.103283_bib18","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1177\/15648265080292S119","article-title":"The worldwide challenge of the dementias: a role for B-vitamins and homocysteine?","volume":"29","author":"Smith","year":"2008","journal-title":"Food Nutr Bull"},{"key":"10.3945\/ajcn.114.103283_bib19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000325581.26991.f2","article-title":"Vitamin B12 status and rate of brain volume loss in community-dwelling elderly","volume":"71","author":"Vogiatzoglou","year":"2008","journal-title":"Neurology"},{"key":"10.3945\/ajcn.114.103283_bib20","doi-asserted-by":"crossref","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B-vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","volume":"5","author":"Smith","year":"2010","journal-title":"PLoS ONE"},{"key":"10.3945\/ajcn.114.103283_bib21","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3945\/ajcn.114.103283_bib22","first-page":"519","article-title":"Plasma omega-3 fatty acid levels negatively and omega-6 fatty acid levels positively associated with other cardiovascular risk factors including homocysteine in severe obese subjects","volume":"21","author":"Mehmetoglu","year":"2012","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.3945\/ajcn.114.103283_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.nut.2010.12.011","article-title":"High consumption of omega-3 polyunsaturated fatty acids decrease plasma homocysteine: a meta-analysis of randomized, placebo-controlled trials","volume":"27","author":"Huang","year":"2011","journal-title":"Nutrition"},{"key":"10.3945\/ajcn.114.103283_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1079\/BJN19820063","article-title":"Effect of experimental folate deficiency on lipid metabolism in liver and brain","volume":"47","author":"Akesson","year":"1982","journal-title":"Br J Nutr"},{"key":"10.3945\/ajcn.114.103283_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/biof.1154","article-title":"Novel insights on interactions between folate and lipid metabolism","volume":"40","author":"da Silva","year":"2014","journal-title":"Biofactors"},{"key":"10.3945\/ajcn.114.103283_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nimg.2002.1040","article-title":"Accurate, robust, and automated longitudinal and cross-sectional brain change analysis","volume":"17","author":"Smith","year":"2002","journal-title":"Neuroimage"},{"key":"10.3945\/ajcn.114.103283_bib27","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1194\/jlr.D007534","article-title":"Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions","volume":"51","author":"Matthan","year":"2010","journal-title":"J Lipid Res"},{"key":"10.3945\/ajcn.114.103283_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial","volume":"27","author":"de Jager","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3945\/ajcn.114.103283_bib29","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/cercor\/bht163","article-title":"Long-chain omega-3 fatty acids improve brain function and structure in older adults","volume":"24","author":"Witte","year":"2014","journal-title":"Cereb Cortex"},{"key":"10.3945\/ajcn.114.103283_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/JAD-2012-121189","article-title":"Efficacy of Souvenaid in mild Alzheimer\u2019s disease: results from a randomized, controlled trial","volume":"31","author":"Scheltens","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3945\/ajcn.114.103283_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/alzrt224","article-title":"The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer\u2019s disease","volume":"5","author":"Shah","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.3945\/ajcn.114.103283_bib32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3945\/ajcn.110.006320","article-title":"Cognitive function after supplementation with B-vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial","volume":"94","author":"Andreeva","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.114.103283_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.plefa.2006.05.009","article-title":"Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins","volume":"75","author":"Polozova","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/ajcn.114.103283_bib34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archneur.63.11.1545","article-title":"Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study","volume":"63","author":"Schaefer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3945\/ajcn.114.103283_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3945\/ajcn.114.103283_bib36","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3945\/ajcn.110.011064","article-title":"Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans","volume":"93","author":"da Costa","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.114.103283_bib37","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/jn\/133.11.3386","article-title":"Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice","volume":"133","author":"Watkins","year":"2003","journal-title":"J Nutr"},{"key":"10.3945\/ajcn.114.103283_bib38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1042\/bj3160805","article-title":"Entry of polyunsaturated fatty acids into the brain: evidence that high-density lipoprotein-induced methylation of phosphatidylethanolamine and phospholipase A2 are involved","volume":"316","author":"Magret","year":"1996","journal-title":"Biochem J"},{"key":"10.3945\/ajcn.114.103283_bib39","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.neurobiolaging.2006.08.003","article-title":"A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer\u2019s disease","volume":"28","author":"Selley","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.3945\/ajcn.114.103283_bib40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1096-4959(03)00277-X","article-title":"Homocysteine-induced changes in brain membrane composition correlate with increased brain caspase-3 activities and reduced chick embryo viability","volume":"136","author":"Miller","year":"2003","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.3945\/ajcn.114.103283_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1743-7075-9-49","article-title":"Combined dietary folate, vitamin B-12, and vitamin B-6 intake influences plasma docosahexaenoic acid concentration in rats","volume":"9","author":"van Wijk","year":"2012","journal-title":"Nutr Metab (Lond)"},{"key":"10.3945\/ajcn.114.103283_bib42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3945\/jn.109.113910","article-title":"DHA may prevent age-related dementia","volume":"140","author":"Cole","year":"2010","journal-title":"J Nutr"},{"key":"10.3945\/ajcn.114.103283_bib43","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1523\/JNEUROSCI.3316-06.2007","article-title":"Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation","volume":"27","author":"Sontag","year":"2007","journal-title":"J Neurosci"},{"key":"10.3945\/ajcn.114.103283_bib44","doi-asserted-by":"crossref","first-page":"e111902","DOI":"10.1371\/journal.pone.0111902","article-title":"A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension","volume":"9","author":"Kemse","year":"2014","journal-title":"PLoS ONE"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523277655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523277655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/102\/1\/215\/23756424\/ajcn103283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T23:40:47Z","timestamp":1683934847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523277655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0002916523277655"],"URL":"https:\/\/doi.org\/10.3945\/ajcn.114.103283","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain atrophy in cognitively impaired elderly: the importance of long-chain \u03c9-3 fatty acids and B vitamin status in a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/ajcn.114.103283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}